New research from a team of genome scientists and DNA damage response experts breaks new ground in understanding the function of a protein currently limited in clinical trials for cancer treatments.
New research reveals how EV-DNA packaging influences antitumor immunity and highlights its potential as a predictive biomarker for colorectal cancer metastasis. Study: Unique structural configuration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results